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VaccineHerein we show for the first time that Schistosoma mansoni adult worms secrete exosome-like extracel-
lular vesicles ranging from 50 to 130 nm in size. Extracellular vesicles were collected from the excretory/
secretory products of cultured adult flukes and purified by Optiprep density gradient, resulting in highly
pure extracellular vesicle preparations as confirmed by transmission electron microscopy and Nanosight
tracking analysis. Extracellular vesicle proteomic analysis showed numerous known vaccine candidates,
potential virulence factors and molecules implicated in feeding. These findings provide new avenues for
the exploration of host–schistosome interactions and offer a potential mechanism by which some vaccine
antigens exert their protective efficacy.
 2015 The Authors. Published by Elsevier Ltd. on behalf of Australian Society for Parasitology Inc. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Schistosomes infect >200 million people worldwide, mostly in
tropical and developing regions. Schistosomiasis is responsible
for the loss of 1.53 million disability-adjusted life years (DALYs)
and up to 280,000 deaths annually in sub-Saharan Africa alone
(Gryseels et al., 2006), and recent estimates indicate that the DALYs
could be substantially higher if pathogenesis grading is revised to
account for individuals who were traditionally classified as
‘‘asymptomatic” (King, 2015). Distinct organs and tissues are
affected during human schistosomiasis due to the different tissue
tropisms displayed by each species. The eggs of Schistosoma man-
soni and Schistosoma japonicum are implicated in hepatosplenic
inflammation and liver fibrosis when trapped in the portal vascu-
lature and surrounding tissues (Gryseels et al., 2006), whereas
the eggs from Schistosoma haematobium are trapped in the mesen-
teries surrounding the bladder and cause a range of sequelae
including haematuria, anaemia, urosepsis, bladder cancer, and
even increase the risk of acquiring HIV (Mayer and Fried, 2007).
The adult worm of S. mansoni inhabits the mesenteric plexus in
the portal system where they live for up to 10 years, as a result of
different immune-evasion strategies employed by the parasite(Collins et al., 2013). Key to the adult fluke’s immunoevasive pro-
wess is the tegumental bilayer, which allows the parasite to mask
its own surface proteins and regenerate damaged tissues thanks to
a population of adult stem cells that can differentiate into many
cell types (Collins et al., 2013). Traditionally, the excretory/secre-
tory (ES) and tegumental proteins from the different life stages of
schistosomes have been analysed to study host–parasite interac-
tions and to develop new therapeutic strategies against this para-
site (Skelly and Wilson, 2006; Loukas et al., 2007; Sotillo et al.,
2015). Interestingly, earlier publications aimed at characterising
the ES products of adult schistosomes described the presence of
proteins that were typically thought of as intracellular in location
(Perez-Sanchez et al., 2006), and this was attributed to the pres-
ence of dying worms in culture. With the recent reports, however,
of the secretion of extracellular vesicles (EVs) by different unicellu-
lar and multicellular parasites, including trematodes such as Echi-
nostoma caproni, Fasciola hepatica, Dicrocoelium dendriticum
(reviewed by Marcilla et al. (2014)), S. japonicum (Wang et al.,
2015) and Opisthorchis viverrini (Chaiyadet et al., 2015), the cellular
origins of many ES proteins have now been resolved.
EVs are membrane-bound vesicles that can be classified into
two major types - exosomes and microvesicles - depending on
their size and specific protein and RNA content. Parasite EVs can
play roles in parasite–parasite and host–parasite communication
(reviewed in Marcilla et al. (2014)), and have also been implicated
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(Chaiyadet et al., 2015). Moreover, EVs from nematode parasites
suppress T helper type 2 immune responses in mice and contain
micro-RNAs (miRNAs) that suppress inflammatory cytokine pro-
duction by epithelial cells (Buck et al., 2014), highlighting their
immunoregulatory function and potential as therapeutic agents
and diagnostic tools. Herein we provide, to our knowledge, the first
evidence of EVs secreted by S. mansoni adult worms in vitro.
Schistosoma mansoni adult worms were obtained by perfusion
from BALB/c mice at 8 weeks p.i. After culturing the worms (300
pairs) in serum-free Basch medium (Basch, 1981) at 37 C, 5%
CO2 at a density of 50 worm pairs in 4 mL of media for 7 days
we collected the ES material and removed dead worms daily. EVs
were purified using an Optiprep discontinuous gradient (ODG)
as described elsewhere (Mathivanan et al., 2010) with slight mod-
ification. Briefly, ES was subjected to differential centrifugation at
4 C (500 g, 2,000 g and 4,000 g for 20 min each) to remove large
parasite material such as eggs and tegumental debris. The super-
natant was then concentrated using a 10 kDa spin concentrator
(Merck Millipore, USA), ultracentrifuged for 45 min at 12,000 g,
and the supernatant was subsequently ultracentrifuged for 3 h at
120,000 g at 4 C using a MLS-50 rotor (Beckman Coulter, USA).
The resultant pellet was resuspended in 70 ll of PBS and subjected
to ODG separation. The ODG was prepared by diluting a 60% Iodix-
anol solution (Sigma Aldrich, USA) with 0.25 M sucrose in 10 mM
Tris-HCl, pH 7.2 to make 40%, 20%, 10% and 5% iodixanol solutions
and then 1.0 ml of these solutions was layered in decreasing den-
sity in an ultracentrifuge tube. The resuspended EVs were added
to the top layer and ultracentrifuged at 120,000 g for 18 h at
4 C. A control tube was similarly prepared using PBS instead of
EVs to measure the density of the different fractions recovered
from the gradient. A total of 12 fractions (330 ll each) were recov-
ered from the ODG, each diluted with 8 ml of PBS containing
1  EDTA-free protease inhibitor cocktail (Santa Cruz, USA), and
concentrated using a 10 kDa spin concentrator to remove the
excess Optiprep solution. All fractions were kept at -80 C until
use. Fractions containing a 340 nm absorbance of 1.09-1.22 (frac-
tions 7-10) were subjected to analysis by transmission electron
microscopy (TEM) to detect the presence of EVs as described pre-
viously (Chaiyadet et al., 2015). Fractions 7-9 contained a clean
preparation of EV-like vesicles, whereas fraction 10 contained both
EVs and protein aggregates (Fig. 1). To confirm the presence and
size of the vesicles from the fractions, an analysis of absolute size
distribution and quantification of EVs from fractions 6-10 was per-
formed by measuring the rate of Brownian motion and diffusion
coefficient with a NanoSight LM10 system (NanoSight, Wiltshire,
United Kingdom). Fractions 6 and 10 were also analysed to obtain
more information about the purity of the preparations. EVs from
fraction 7 had a size of 77.4 ± 34.8 nm, whereas the size of EVs in
fractions 8 and 9 was 96.4 ± 34.8 nm and 97.9 ± 28.5 nm, respec-
tively (Fig. 2). While it is generally unclear how to classify the dif-
ferent subpopulations of EVs (Webber and Clayton, 2013),
particularly those of parasite origin (Marcilla et al., 2014), the size
of EVs found in fractions 7–9 corresponds to exosome-like vesicles.
The number of particles/ml varied from 8.362  109 in fraction 7 to
2.15  1010 in fraction 8 and 1.83  1010 in fraction 9 (Supplemen-
tary Fig. S1). Fractions 6 and 10 contained 2.46  109 and
3.55  109 particles/ml, respectively. The number of vesicles/lg
of protein ratio (P/lg) has been proposed as a good approach to
measure the purity of vesicle preparations (Webber and Clayton,
2013). The highest P/lg was found in fractions 8 and 9
(1.12  108 and 1.3  108 P/lg, respectively) (Supplementary
Table S1), which agrees with the predictions from our TEM and
Nanosight studies. Despite the ratios being lower than those pro-
posed by Webber and Clayton (2013), the authors also suggested
that EV preparations obtained from fluids other than cell cultureor from different organisms could have different ratios as the pro-
tein content of the vesicles is not comparable between organisms
(Webber and Clayton, 2013). Therefore, we propose that a ratio
of 1  108 P/lg could represent high quality vesicular preparations
from schistosomes, and perhaps other helminth parasites.
A total of 2 lg from each fraction was electrophoresed on an
SDS-gel and silver-stained. While fractions 7–9 contained the
majority of the proteins, there were significant differences with
the other fractions, confirming the isolation of pure vesicles, and
minimal contamination with other soluble proteins (Fig. 2). We
believe this is the first time that ODG has been used to isolate
and characterise the EVs from helminths, and it has proven to be
a reliable method to obtain pure, clean vesicles from the ES prod-
ucts of S. mansoni. For the proteomic analysis of the vesicles, a total
of 2 lg from fractions 7, 8 and 9 was combined and elec-
trophoresed on a 15% SDS-gel. The gel was then cut into 12 slices
and each slice was subjected to reduction, alkylation and trypsin
digestion and analysed using the NanoSpray II of a QSTAR Elite
instrument (Applied Biosystems, USA) as described previously
(Sotillo et al., 2014). The acquired MS/MS spectra were searched
against an in-house built database containing the S. mansoni pre-
dicted proteome from the publicly available genome (Berriman
et al., 2009) and the proteins from the common Repository of
Adventitious Proteins (cRAP, http://www.thegpm.org/crap/)
appended with reversed decoy sequences using Mascot (Matrix
Science; version 2.5) with a P value < 0.05, and against the same
database using X!Tandem and MS-GF + search engines. Identifica-
tion results were validated using PeptideShaker v0.41.1 (Vaudel
et al., 2015); the False Discovery Rate was evaluated at Peptide
Spectra matching-, peptide- and protein-levels and all levels were
set at a maximum of 1%, and only proteins containing at least one
unique peptide validated by PeptideShaker were considered as
identified. The acquired MS/MS spectra were searched against
the Mus musculus database from Uniprot to search for host pro-
teins, but no significant results were obtained. We identified a total
of 83 different S. mansoni proteins (Supplementary Table S2),
including exosome markers such as the tetraspanins (TSP)s Sm-
TSP-1, Sm-TSP-2 (the S. mansoni homologue of the typical human
exosome marker CD63), Sm-TSP-4, TSP-18 and tetraspanin D76,
Heat Shock protein (HSP)-70, enolase and elongation factor 1-
alpha. Of the 83 identified proteins, 17 (20%) were homologous
to proteins previously identified in EVs from E. caproni, 24 (29%),
F. hepatica, 17 (20%) from D. dendriticum and 19 (23%) from O.
viverrini, which implies a specific cargo in S. mansoni EVs compared
with other trematodes, a difference probably attributed to
schistosome-specific characteristics of parasitism such as sexual
dimorphism, hematophagy and the final site of predilection in
the host. While every effort was made to minimise the occurrence
of eggs in the adult worm cultures (by removing media and eggs
daily), we cannot discount the possibility of the presence of egg-
derived EV proteins (if, indeed, they are secreted by eggs) in our
preparation. A comparison of our proteome dataset with that of
the egg secretome (Cass et al., 2007) revealed that, while there
were proteins in common, the majority of these were molecules
expressed in multiple life-cycle stages (e.g. annexin, ferritin, eno-
lase), and the most abundant and unique egg-secreted proteins
(e.g. Omega-1, IPSE/alpha-1 and Sm-p40) were not present in our
dataset, indicating that the EV preparation was unlikely to be heav-
ily contaminated with egg-derived EVs.
The most abundant protein in S. mansoni EVs, based on spec-
trum counting, is a saposin B domain-containing protein.
Saposin-like proteins have been described from helminth parasites
and are proposed to be haemolytic, playing a role in the nutrient
acquisition process of haematophagous parasites by disrupting
red blood cell (RBC) membranes to liberate haemoglobin (Don
et al., 2008). A number of ferritin isoforms are also highly repre-
Fig. 1. Extracellular vesicles (EVs) secreted by Schistosoma mansoni. Transmission electron micrographs showing the presence of extracellular vesicles after Optiprep
gradient ultracentrifugation of Schistosoma mansoni excretory/secretory products. Fractions 7 (A), 8 (B), 9 (C) and 10 (D) were deposited onto a carbon-formvar coated grid,
negatively stained in aqueous uranyl acetate and analysed on a JEM1011 transmission electron microscope.
Fig. 2. Proteomic characterisation of the Schistosoma mansoni adult worm extracellular vesicles. The 12 fractions obtained from an Optiprep density gradient were
electrophoresed on a SDS-gel and silver-stained (A). The presence of Sm-TSP-2 was confirmed by western blot in the fractions containing extracellular vesicles (B). The lower
band at 23 kDa depicts monomeric Sm-TSP-2 and the higher bands at 46 and 69 kDa depict dimeric and trimeric forms of the protein. Moreover, Sm-TSP-2 was identified
by tandem mass spectrometry in gel slices corresponding to both monomeric and dimeric forms, despite being reduced and alkylated.
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EVs, together with saposin-like proteins and other molecules
involved in the feeding pathway (e.g.: aminopeptidases and meta-
bolic enzymes), suggest a role for EVs in the nutrient acquisition
process. An extension to this hypothesis is that S. mansoni EVs
could be involved in cross-talk between paired male and female
worms, perhaps in a nutrient transfer context, as there is evidence
of EV-mediated communication between other parasites.
Interestingly, 26 (31%) of the identified proteins are homo-
logues of previously described vaccine candidates or therapeutic
agents (see Table 1). Some of these proteins (e.g. enolase, HSP-70
and Glutathione-S-transferase) are common to multiple life-cycle
stages, including eggs (Cass et al., 2007) (Supplementary
Table S2), implying that vaccines based on these proteins could
simultaneously target different parasite stages. Moreover, four of
the five most abundant proteins are known S. mansoni vaccine can-
didates or homologues of protective antigens from other flukes,including Saposin B domain-containing protein (Espino and
Hillyer, 2003), Sm-TSP-2 (Tran et al., 2006), Sm29 (Cardoso et al.,
2006) and cytoplasmic dynein light chain (Rezende et al., 2011).
The fact that some of the proteins contained in S. mansoni EVs
are efficacious in animal models as subunit vaccines (for example,
Triose Phosphate Isomerase and Glyceraldehyde-6-Phosphate
Dehydrogenase), previously presented a conundrum for vaccinolo-
gists as it was unclear how these antigens could be accessible to
the immune system in a live fluke, but their presence in EVs
implies a mechanism by which these molecules could egress from
the fluke to be internalised by host cells, including antigen present-
ing cells. Given the important roles that EVs play in cell-to-cell
communication and, presumably in the case of parasite EVs, the
orchestration of parasitism, it is plausible that disruption of EV
function and/or uptake by target cells through antibody-
mediated neutralisation is a major mechanism by which these vac-
cines exert their efficacy. Indeed, TSPs have been described to play
Table 1
Homologues of vaccine candidates from different trematodes found in Schistosoma mansoni adult worm extracellular vesicles. Proteins are sorted by spectrum counting, which is











Smp_194910 Saposin B domain-containing protein 0.144736842 Yes No 2
Smp_181530 TSP-2 0.112359551 Yes Yes 4
Smp_072190 Sm29 0.086538462 No No 2
Smp_040680 Cytoplasmic dynein light chain 0.073333333 No Yes 4
Smp_130100 Saposin containing protein 0.066406250 No No 3
Smp_045200 22.6 kda tegument antigen 0.033383459 No No 13
Smp_059480 Thioredoxin peroxidase 0.031590414 No Yes 6
Smp_116000 Annexin 0.022988506 No Yes 2
Smp_077720 Annexin 0.019068946 No Yes 16
Smp_158110.1 Thioredoxin peroxidase 0.016666667 No Yes 1
Smp_074140 Annexin 0.016339869 No Yes 3
Smp_068530 Syntenin 0.012755102 No Yes 4
Smp_095520 Dynein light chain 0.011235955 No Yes 4
Smp_086480 Antigen sm21.7 0.010869565 No No 7
Smp_155310.1 TSP-1 0.009803922 Yes Yes 3
Smp_102070 Glutathione S-transferase 26 kda (GST 26) 0.009174312 No Yes 2
Smp_106930.1 Heat shock protein 70 0.008634560 No Yes 15
Smp_030000 Leucine aminopeptidase (M17 family) 0.006830601 No No 9
Smp_045560 Annexin 0.006734007 No Yes 8
Smp_056970.1 Glyceraldehyde-3-phosphate dehydrogenase 0.002958580 No Yes 3
Smp_074150.1 Annexin 0.002739726 No Yes 1
Smp_024110 Enolase 0.002481390 No Yes 7
Smp_045550 Annexin 0.002398082 No Yes 2
Smp_104270 Ectonucleotide pyrophosphatase/
phosphodiesterase
0.002358491 Yes No 4
Smp_009760 14-3-3 protein 0.001984127 No Yes 2
Smp_157500 Calpain (C02 family) 0.001512859 No No 4
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cholangiocytes (Chaiyadet et al., 2015), where their uptake by cells
was blocked with anti-TSP antibodies, further supporting this
hypothesis.
To confirm the presence of the Sm-TSP-2 vaccine antigen in S.
mansoni EVs, we performed a western blot of the different fractions
purified from the ODG with polyclonal anti-Sm-TSP-2 sera (Tran
et al., 2006). A total of 2 lg of EVs from each fraction was separated
on a 15% SDS-gel, transferred to nitrocellulose membranes, blocked
overnight with PBS-Tween 0.05% (PBST) containing 5% skimmed
milk and incubated with antisera to Sm-TSP-2 (1:500 in PBST) for
2.0 h at room temperature. Membranes were then probed with
anti-rabbit IgG-horse radish peroxidae (HRP) (1:2000 in PBST)
(Chemicon) for 1.0 h at room temperature and developed using
the Amersham ECL Western Blotting Detection Kit. Sm-TSP-2 pres-
ence was confirmed in fractions 7–9; fractions 1–4 and fraction 6
were weakly positive, possibly due to contamination of these frac-
tions with a small number of vesicles during ODG or sloughed
tegument membrane that fractionated differently to EVs
(Fig. 2B). We are now using anti-Sm-TSP-2 antibodies to attempt
to purify S. mansoni EVs, in the same way that anti-CD63 antibod-
ies are used to isolate human exosomes (Caby et al., 2005). The use
of Sm-TSP-2 antibodies could also serve as a quality control reagent
for S. mansoni EV isolation after ODG.
Herein we have isolated and characterised, to our knowledge
for the first time, the EVs secreted by S. mansoni adult worms.
These EVs contain numerous proteins known to be efficacious as
anti-schistosome vaccines. Further investigation of S. mansoni
EVs represents a unique avenue to explore Schistosoma–host rela-
tionships and holds significant potential for the design of novel
therapeutics against this debilitating neglected tropical disease.Acknowledgments
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